Back to Search Start Over

Solvent-Mediated Polymorphic Transformations in Molten Polymers: The Account of Acetaminophen.

Authors :
Hernández Espinell JR
Toro V
Yao X
Yu L
Lopéz-Mejías V
Stelzer T
Source :
Molecular pharmaceutics [Mol Pharm] 2022 Jul 04; Vol. 19 (7), pp. 2183-2190. Date of Electronic Publication: 2022 Apr 27.
Publication Year :
2022

Abstract

Solvent-mediated polymorphic transformations (SMPTs) employing nonconventional solvents (polymer melts) is an underexplored research topic that limits the application of polymer-based formulation processes. Acetaminophen (ACM), a widely studied active pharmaceutical ingredient (API), is known to present SMPTs spontaneously (<30 s) in conventional solvents such as ethanol. In situ Raman spectroscopy was employed to monitor the induction time for the SMPT of ACM II to I in polyethylene glycol (PEG) melts of different molecular weights ( M <subscript>w</subscript> , 4000, 10 000, 20 000, 35 000 g/mol). The results presented here demonstrate that the induction time for the SMPT of ACM II to I in PEG melts is driven by its diffusivity through the polymer melts. Compared to conventional solvents ( i.e. , ethanol) the mass transfer (diffusion coefficient, D ) in melts is significantly hindered ( D <subscript>ethanol</subscript> = 4.84 × 10 <superscript>-9</superscript> m <superscript>2</superscript> /s > D <subscript>PEGs</subscript> = 5.32 × 10 <superscript>-11</superscript> -8.36 × 10 <superscript>-14</superscript> m <superscript>2</superscript> /s). Ultimately, the study proves that the induction time for the SMPT can be tuned by understanding the dispersant's physicochemical properties ( i.e. , η) and, thus, the D of the solute in the dispersant. This allows one to kinetically access and stabilize metastable forms or delay their transformations under given process conditions.

Details

Language :
English
ISSN :
1543-8392
Volume :
19
Issue :
7
Database :
MEDLINE
Journal :
Molecular pharmaceutics
Publication Type :
Academic Journal
Accession number :
35475360
Full Text :
https://doi.org/10.1021/acs.molpharmaceut.2c00035